Unknown

Dataset Information

0

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.


ABSTRACT: BACKGROUND:Occult metastatic tumors, below imaging thresholds, are a limitation of staging systems that rely on cross-sectional imaging alone and are a cause of the routine understaging of pancreatic ductal adenocarcinomas (PDACs). We investigated circulating tumor cells (CTCs) as a preoperative predictor of occult metastatic disease and as a prognostic biomarker for PDAC patients. EXPERIMENTAL DESIGN:A total of 126 patients (100 with cancer, 26 with benign disease) were enrolled in our study and CTCs were identified and enumerated from 4 mL of venous blood using the microfluidic NanoVelcro assay. CTC enumeration was correlated with clinicopathologic variables and outcomes following both surgical and systemic therapies. RESULTS:CTCs were identified in 78% of PDAC patients and CTC counts correlated with increasing stage (? = 0.42, p < 0.001). Of the 53 patients taken for potentially curative surgery, 13 (24.5%) had occult metastatic disease intraoperatively. Patients with occult disease had significantly more CTCs than patients with local disease only (median 7 vs. 1 CTC, p < 0.0001). At a cut-off of three or more CTCs/4 mL, CTCs correctly identified patients with occult metastatic disease preoperatively (area under the receiver operating characteristic curve 0.82, 95% confidence interval (CI) 0.76-0.98, p < 0.0001). CTCs were a univariate predictor of recurrence-free survival following surgery [hazard ratio (HR) 2.36, 95% CI 1.17-4.78, p = 0.017], as well as an independent predictor of overall survival on multivariate analysis (HR 1.38, 95% CI 1.01-1.88, p = 0.040). CONCLUSIONS:CTCs show promise as a prognostic biomarker for PDAC patients at all stages of disease being treated both medically and surgically. Furthermore, CTCs demonstrate potential as a preoperative biomarker for identifying patients at high risk of occult metastatic disease.

SUBMITTER: Court CM 

PROVIDER: S-EPMC5896564 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.

Court Colin M CM   Ankeny Jacob S JS   Sho Shonan S   Winograd Paul P   Hou Shuang S   Song Min M   Wainberg Zev A ZA   Girgis Mark D MD   Graeber Thomas G TG   Agopian Vatche G VG   Tseng Hsian-Rong HR   Tomlinson James S JS  

Annals of surgical oncology 20180213 4


<h4>Background</h4>Occult metastatic tumors, below imaging thresholds, are a limitation of staging systems that rely on cross-sectional imaging alone and are a cause of the routine understaging of pancreatic ductal adenocarcinomas (PDACs). We investigated circulating tumor cells (CTCs) as a preoperative predictor of occult metastatic disease and as a prognostic biomarker for PDAC patients.<h4>Experimental design</h4>A total of 126 patients (100 with cancer, 26 with benign disease) were enrolled  ...[more]

Similar Datasets

| S-EPMC8105246 | biostudies-literature
| S-EPMC4551342 | biostudies-literature
| S-EPMC5528974 | biostudies-other
| S-EPMC5788622 | biostudies-literature
| S-EPMC7004068 | biostudies-literature
| S-EPMC6895979 | biostudies-literature
| S-EPMC5407944 | biostudies-literature
| S-EPMC7406781 | biostudies-literature
| S-EPMC7665234 | biostudies-literature
| S-EPMC7226515 | biostudies-literature